期刊文献+

多发性骨髓瘤血栓形成机制的研究现状 被引量:5

Present status of studies on mechanism of thrombosis in multiple myeloma
下载PDF
导出
摘要 多发性骨髓瘤(multiple myeloma,MM)是一种浆细胞异常增生的恶性肿瘤。MM患者血栓栓塞事件发生率明显高于其他实体瘤,且血栓的发展影响患者预后及远期生存率。MM患者血栓的形成原因除了包括疾病本身的合并症、瘤细胞因素,相关治疗药物也是一个重要的因素。因此了解骨髓瘤患者血栓形成相关机制及预防非常重要。 Multiple myeloma( MM) is a malignant tumor with abnormal proliferation of plasma cells. Individuals with MM have a higher risk of thrombosis than other solid tumors,and the development of thrombosis would impact the prognosis and long-term survival.The chemotherapy played an important role in thrombosis in MM except for the complications of the disease itself and the factors of tumor cells. Therefore,it is very important to understand the mechanisms and prevention of thrombosis in MM.
作者 杨艳 杨林花
出处 《首都医科大学学报》 CAS 2014年第5期581-584,共4页 Journal of Capital Medical University
关键词 多发性骨髓瘤 血栓 机制 multiple myeloma thrombosis mechanism
  • 相关文献

参考文献33

  • 1Lee A Y,Levine M N.Venous thromboembolism and cancer:Risks and outcomes[J] .Circulation,2003,107 (23Supple 1):117-121.
  • 2Musallam K M,Dahdaleh F S,Shamseddine A l,et al.Incidence and prophylaxis of venous thromboembolic events in multiplemveloma patients receiving immunomodulatory therapy[J] .Tbromb Res,2009,123(5):679-686.
  • 3杨林花.多发性骨髓瘤的凝血异常[J].临床血液学杂志,2012,25(4):414-417. 被引量:14
  • 4Zangari M,Tricot G,Polavaram L,et al.Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone[J] .J Clin Oncol,2010,28(1):132-135.
  • 5Smith R A,Cokkinides V,Eyre H J.American Cancer Society guidelines for the early detection of cancer,2006[J] .CA Cancer J Clin,2006,56(1):11-25.
  • 6Shimizu K,Itoh J.A possible link between Trousseau's syndrome and tissue factor producing plasma cells[J] .Am J Hematol,2009,84(6):382-385.
  • 7候彦飞,杨林花,任方刚,张耀方,秦秀玉,白斯君,杨晨,王云鹏.组织因子微粒在多发性骨髓瘤中的表达及临床意义[J].临床血液学杂志,2014,27(4):573-576. 被引量:2
  • 8Auwerda J J,Sonneveld P,de Maat M P,et al.Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma[J] .Haematologica,2007,92(2):279-280.
  • 9白洁,薛艳萍,许现辉,张磊,田萌苏,沈琳,张红云,杨仁池.骨髓增殖性肿瘤患者活化蛋白C抵抗和凝血功能异常研究[J].中华血液学杂志,2011,32(3):187-190. 被引量:3
  • 10De Lucia D,De Vita F,Orditura M,et al.Hypercoagulable state in patients with advanced gastrointestinal cancer:evidence for an acquired resistance to activated protein C[J] .Tumori,1997,83(6):948-952.

二级参考文献53

  • 1Elliott MA,Tefferi A.Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia.Br J Haematol,2005,128:275-290.
  • 2Tefferi A,Elliott M.Thrombosis in myeloproliferative disorders:prevalence,prognostic factors,and the role of leukocytes and JAK2V617F.Semin Thromb Hemost,2007,33:313-320.
  • 3Carobbio A,Finazzi G,Guerini V,et al.Leukocytosis is a risk factor for thrombosis in essential thrombocythemia:interaction with treatment,standard risk factors,and Jak2 mutation status.Blood,2007,109:2310-2313.
  • 4Landolfi R,Di Gennaro L,Barbui T,et al.Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.Blood,2007,109:2446-2452.
  • 5Finazzi G,Rambaldi A,Guerini V,et al.Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status.Haematologica,2007,92:135-136.
  • 6Falanga A,Marchetti M,Barbui T,et al.Pathogenesis of thrombosis in essential thrombo-cythemia and polycythemia vera:the role of neutrophils.Semin Hemato1,2005,42:239-247.
  • 7Burgaleta C,Gonzalez N,Cesar J.Increased CD11/CD18 expression and altered metabolicactivity on polymorphonuclear leukocytes from patients with polycythemia vera and essentialthrombocythemia.Acta Haemato1,2002,108:2328.
  • 8Dielis AW,Castoldi E,Spronk HM,et al.Coagulation factors and the protein C system as determinants of thrombin generation in a normal population.J Thromb Haemost,2008,6:125-131.
  • 9Bucalossi A,Marotta G,Bigazzi C,et al.Reduction of antithrombin Ⅲ,protein C,and protein S levels and activated protein C resistance in polycythemia vera and essentia thrombocythemia patients with thrombosis.Am J Hematol,1996,52:14-20.
  • 10Xu X,Zhang Q,Luo J,et al.JAK2(V617F):Prevalence in a large Chinese hospital population.Blood,2007,109:339-342.

共引文献22

同被引文献49

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部